RE:The Business of Biotech interview...@fox. First, let me say I liked the talk. I am not sure you heard MC exactly as spoken. In reference to Phase 3, he clearly states we would like to partner in it, play an active roll. That was spoken roughly half way through. At the end of the talk he mentions buyout by pharma. He has some weight off his shoulders thanks to GOBLET, and naturally it will be tough to let go if ONC is bought out.
I am not satisfied that he is ready for a buyout. Yet a buyout seems to be the best way to get pela to patients, excepting some form of accelerated approval. Time will tell.